🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase III trial compares the effect of adding cabozantinib to avelumab...
Status
Active Not Recruiting
Location
Mayo Clinic Hospital in Arizona
Start Date
2022-06-03
Trial ID
NCT05092958
This phase II/III trial compares the effect of the combination treatment wi...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2023-03-30
Trial ID
NCT05432791
This phase I trial tests the safety, side effects, and best dose of nivolum...
Status
Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2022-11-03
Trial ID
NCT05272384
This phase II trial tests whether mosunetuzumab and/or polatuzumab vedotin ...
Status
Recruiting
Location
Banner University Medical Center - Tucson
Start Date
2023-06-12
Trial ID
NCT05633615
The purpose of this study is to test the utility of PET/MRI in diagnosis an...
Status
Unknown
Location
Steffen Husby
Start Date
2018-10-18
Trial ID
NCT03640637
Neurogenetic diseases (NGD) represent rare and hereditary forms of neurolog...
Status
Recruiting
Location
Chu de Bordeaux
Start Date
2024-07-18
Trial ID
NCT06048523
Treatments Being Tested
This ALCHEMIST trial studies genetic testing in screening patients with sta...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2014-09-26
Trial ID
NCT02194738
Treatments Being Tested
The purpose of this study is to evaluate high and low areas of growth, or p...
Status
Completed
Location
Memorial Sloan-Kettering Cancer Center
Start Date
2009-09-16
Trial ID
NCT00979810
Treatments Being Tested
Identifying hypercortisolism patients at risk for cardio-vascular events de...
Status
Completed
Location
Assistance Publique Hôpitaux Marseille
Start Date
2014-12-08
Trial ID
NCT02335996
Treatments Being Tested
This phase II trial tests how well niraparib and dostarlimab work in treati...
Status
Active Not Recruiting
Location
Ohio State University Comprehensive Cancer Center
Start Date
2023-10-17
Trial ID
NCT05870761
Treatments Being Tested